These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 28928286)

  • 1. HPV Integration in HNSCC Correlates with Survival Outcomes, Immune Response Signatures, and Candidate Drivers.
    Koneva LA; Zhang Y; Virani S; Hall PB; McHugh JB; Chepeha DB; Wolf GT; Carey TE; Rozek LS; Sartor MA
    Mol Cancer Res; 2018 Jan; 16(1):90-102. PubMed ID: 28928286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the tumor immune microenvironment in human papillomavirus-positive and -negative head and neck squamous cell carcinomas.
    Succaria F; Kvistborg P; Stein JE; Engle EL; McMiller TL; Rooper LM; Thompson E; Berger AE; van den Brekel M; Zuur CL; Haanen J; Topalian SL; Taube JM
    Cancer Immunol Immunother; 2021 May; 70(5):1227-1237. PubMed ID: 33125511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of the tumor microbiome, molecular profiles, and immune cell abundances by HPV status in mucosal head and neck cancers and their impact on survival.
    Upadhyay R; Dhakal A; Wheeler C; Hoyd R; Jagjit Singh M; Karivedu V; Bhateja P; Bonomi M; Valentin S; Gamez ME; Konieczkowski DJ; Baliga S; Grecula JC; Blakaj DM; Gogineni E; Mitchell DL; Denko NC; Spakowicz D; Jhawar SR
    Cancer Biol Ther; 2024 Dec; 25(1):2350249. PubMed ID: 38722731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV Integration in Head and Neck Squamous Cell Carcinomas: Cause and Consequence.
    Speel EJ
    Recent Results Cancer Res; 2017; 206():57-72. PubMed ID: 27699529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of HPV Infection on the Immune System in Oropharyngeal and Non-Oropharyngeal Squamous Cell Carcinoma: A Systematic Review.
    Lechien JR; Seminerio I; Descamps G; Mat Q; Mouawad F; Hans S; Julieron M; Dequanter D; Vanderhaegen T; Journe F; Saussez S
    Cells; 2019 Sep; 8(9):. PubMed ID: 31510065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV-positive status associated with inflamed immune microenvironment and improved response to anti-PD-1 therapy in head and neck squamous cell carcinoma.
    Wang J; Sun H; Zeng Q; Guo XJ; Wang H; Liu HH; Dong ZY
    Sci Rep; 2019 Sep; 9(1):13404. PubMed ID: 31527697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV33+ HNSCC is associated with poor prognosis and has unique genomic and immunologic landscapes.
    Chatfield-Reed K; Gui S; O'Neill WQ; Teknos TN; Pan Q
    Oral Oncol; 2020 Jan; 100():104488. PubMed ID: 31835137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological network analysis in HPV associated head and neck squamous cancer and implications for disease prognosis.
    Chen X; Yan B; Lou H; Shen Z; Tong F; Zhai A; Wei L; Zhang F
    Mol Immunol; 2018 Apr; 96():28-36. PubMed ID: 29477933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas.
    Riva G; Pecorari G; Biolatti M; Pautasso S; Lo Cigno I; Garzaro M; Dell'Oste V; Landolfo S
    Mol Biol Rep; 2019 Jun; 46(3):3333-3347. PubMed ID: 30980272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct immune evasion in APOBEC-enriched, HPV-negative HNSCC.
    Messerschmidt C; Obermayer B; Klinghammer K; Ochsenreither S; Treue D; Stenzinger A; Glimm H; Fröhling S; Kindler T; Brandts CH; Schulze-Osthoff K; Weichert W; Tinhofer I; Klauschen F; Keilholz U; Beule D; Rieke DT
    Int J Cancer; 2020 Oct; 147(8):2293-2302. PubMed ID: 32468570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of antibody responses to nonviral cancer antigens in head and neck squamous cell carcinoma patients differ by human papillomavirus status.
    Gangkofner DS; Holzinger D; Schroeder L; Eichmüller SB; Zörnig I; Jäger D; Wichmann G; Dietz A; Broglie MA; Herold-Mende C; Dyckhoff G; Boscolo-Rizzo P; Ezic J; Marienfeld RB; Möller P; Völkel G; Kraus JM; Kestler HA; Brunner C; Schuler PJ; Wigand M; Theodoraki MN; Doescher J; Hoffmann TK; Pawlita M; Butt J; Waterboer T; Laban S
    Int J Cancer; 2019 Dec; 145(12):3436-3444. PubMed ID: 31407331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type I conventional dendritic cells and CD8
    Kirchner J; Plesca I; Rothe R; Resag A; Löck S; Benešová I; Rupp L; Linge A; Wehner R; Krause M; Schmitz M
    Front Immunol; 2024; 15():1414298. PubMed ID: 38938577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Papillomavirus Genome Integration and Head and Neck Cancer.
    Pinatti LM; Walline HM; Carey TE
    J Dent Res; 2018 Jun; 97(6):691-700. PubMed ID: 29227715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy Advances in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Its Relationship With Human Papillomavirus.
    Wang H; Zhao Q; Zhang Y; Zhang Q; Zheng Z; Liu S; Liu Z; Meng L; Xin Y; Jiang X
    Front Immunol; 2021; 12():652054. PubMed ID: 34305889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of Tumor Antigen-specific T-cell Responses by Immune Checkpoint Blockade in Human Papillomavirus-related Head and Neck Squamous Cell Carcinoma.
    Chikamatsu K; Ida S; Masuda K; Horikawa M; Hoshino N; Takahashi H; Tada H; Oyama T; Takeda S; Tomidokoro Y; Motegi M
    Anticancer Res; 2024 Jul; 44(7):2921-2931. PubMed ID: 38925841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of high-risk human papillomavirus into cellular cancer-related genes in head and neck cancer cell lines.
    Walline HM; Goudsmit CM; McHugh JB; Tang AL; Owen JH; Teh BT; McKean E; Glover TW; Graham MP; Prince ME; Chepeha DB; Chinn SB; Ferris RL; Gollin SM; Hoffmann TK; Bier H; Brakenhoff R; Bradford CR; Carey TE;
    Head Neck; 2017 May; 39(5):840-852. PubMed ID: 28236344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of B lymphocyte infiltration in HPV
    Zhang S; Wang B; Ma F; Tong F; Yan B; Liu T; Xie H; Song L; Yu S; Wei L
    Cancer Sci; 2021 Apr; 112(4):1402-1416. PubMed ID: 33529452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Immune-Related Prognostic Biomarkers Associated with HPV-Positive Head and Neck Squamous Cell Carcinoma.
    Chen Y; Nie J; Li X; Fan T; Deng X; Liang D; Song G
    J Immunol Res; 2021; 2021():6661625. PubMed ID: 33506058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV16 E5 Mediates Resistance to PD-L1 Blockade and Can Be Targeted with Rimantadine in Head and Neck Cancer.
    Miyauchi S; Sanders PD; Guram K; Kim SS; Paolini F; Venuti A; Cohen EEW; Gutkind JS; Califano JA; Sharabi AB
    Cancer Res; 2020 Feb; 80(4):732-746. PubMed ID: 31848196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma cell marker, immunoglobulin J polypeptide, predicts early disease-specific mortality in HPV+ HNSCC.
    Gui S; O'Neill WQ; Teknos TN; Pan Q
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.